Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
UC expert comments on study to NBC News
The University of Cincinnati's Alberto Espay, MD, commented to NBC News on new research published Oct. 24 that found semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes.
The new study compared semaglutide to seven other diabetes drugs, including metformin, insulin and older GLP-1 drugs, including liraglutide.
Researchers found that patients prescribed semaglutide had a significantly lower risk for Alzheimer’s disease than those who had taken one of the seven other diabetes drugs. The results were consistent across gender, age and weight.
Espay, who was not involved in the study, told NBC News more research is needed to determine if the drugs actually work against Alzheimer's. He noted previous early research showed similar positive effects for people who took drugs including statins or insulin, but none of those potential treatments panned out.
“Just as with statins, NSAIDs and insulin, we should be cautious about claiming semaglutide can treat or prevent Alzheimer’s based on this study alone,” Espay said.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
Can coal make a comeback?
February 24, 2026
Bloomberg Law speaks with Joseph Tomain, Dean Emeritus and Wilbert and Helen Ziegler Professor of Law at UC, about the federal government's push to promote use of coal plants for energy generation.
UC alum aims for summer Olympic debut
February 23, 2026
With the 2026 Winter Olympic Games coming to a close, attention now turns to the summer games coming up in Los Angeles in 2028. Beach sprint rowing is a relatively new sport that is surging in popularity due to its inclusion in the 2028 Los Angeles Olympic Games. Spectrum News 1 spoke with Lindner College of Business alum and most-decorated beach sprint rower of all time, Christopher Bak, on his Olympic-sized goals.
CCM singers advance to Metropolitan Opera Laffont Competition semifinals
February 23, 2026
Three UC College-Conservatory of Music alumni and one current student are semifinalists in the 2026 Metropolitan Opera Eric and Dominique Laffont Competition. One of the most prestigious singing competitions in the world, the Laffont Competition's national semifinals take place on Sunday, March 15, 2026.